Sirtex
is a Massachusetts-based medical device company that develops and markets minimally invasive interventional systems for the treatment of liver cancer... Read moreSirtex
is a Massachusetts-based medical device company that develops and markets minimally invasive interventional systems for the treatment of liver cancer... Read more
News
Sep 16, 2024
Drug Delivery Business
Sirtex: Sirtex Medical begins European launch for microsphere delivery system following EU approval
Mar 25, 2024
Citybizlist
Sirtex: Sirtex Medical Appoints Matt Schmidt as Chief Executive Officer
Oct 30, 2023
Pharmabiz
Sirtex: Sirtex Medical introduces new LAVA Liquid Embolic System to treat peripheral vascular haemorrhage
Sep 11, 2023
Pharmabiz
Sirtex: Sirtex Medical enter collaboration agreement to distribute Magle Group's chemoembolization product, EmboCept S DSM 50 m
Sep 15, 2022
Markets Insider
Sirtex: Sirtex Medical secures positive approval of SIR-Spheres Y-90 resin microspheres for HCC treatment in Brazil
Feb 11, 2022
Pharmabiz
Sirtex: China NMPA approves Grand Pharma's radiopharmaceutical drugs SIRSpheres Y90 microsphere inj to treat colorectal cancer liver metastases
Feb 09, 2022
Markets Insider
Sirtex: Sirtex Medical and Grand Pharmaceutical Group Limited receive NDA approval of SIR-Spheres Y-90 resin microspheres in China from the National Medical Products Administration
Oct 13, 2021
ChinaBio Today
Sirtex: Sirtex Doses First Patient in China Trial of Microsphere Radiation Therapy
Jun 08, 2021
BioSpace
Sirtex: Sirtex Medical provides donations to Massachusetts Institute of Technology (MIT) and Brigham and Women's Hospital in support of the Artzi Lab, as part of Sirtex's corporate citizenship strategy to support research and innovation
May 10, 2021
Cision Canada
Press Release: Sirtex : DOORwaY-90 study for SIR-Spheres therapy as first-line treatment for hepatocellular carcinoma enrolls first patient
Sirtex Competitors
1
2
3
4
5
6
7
8
9
10